JOURNAL OF ELECTROCARDIOLOGY, vol.39, no.2, pp.211-218, 2006 (SCI-Expanded)
Objective: We sought to examine the effect of trimetazidine (TMZ) on heart rate variability (HRV), endothelin-1 (ET-1), NO, and anginal symptoms in patients with slow coronary artery flow (SCAF).